Press releases | Finanzwire

Basculer en Français

11200	Companies
247902	Keywords
175686	Articles
133992	Press releases

Home
Press releases

PRESS RELEASE

published on 08/28/2025 at 07:29, 1 year 1 month ago

Q2 and H1 2025 financial results: Delivery Hero accelerates growth and expands profitability, updates full-year guidance
Delivery Hero SE reports accelerated growth and enhanced profitability in Q2 and H1 2025 financial results, updating full-year guidance. Company demonstrates strong operational performance and robust financial position

Financial Results Delivery Hero Full-year Guidance Q2 2025 H1 2025
PRESS RELEASE

published on 08/28/2025 at 07:16, 1 year 1 month ago

Adler Group S.A. announces results for H1 2025 demonstrating strong performance in the rental business
Adler Group S.A. announces strong H1 2025 results with 3.4% like-for-like rental growth and €285m cash position. Focus on Berlin residential portfolio

Financial Performance Adler Group S.A. Rental Business Berlin Portfolio H1 2025 Results
PRESS RELEASE

published on 08/28/2025 at 07:10, 1 year 1 month ago

EDAG Engineering Group AG: Decline in revenues and EBIT due to ongoing market restraint in the first half of 2025, expansion of defence activities
EDAG Engineering Group AG reports decline in revenues and EBIT for the first half of 2025 due to market restraint, focusing on defence activities for growth

Revenues EBIT EDAG Engineering Group AG Defence Activities Market Restraint
PRESS RELEASE

published on 08/28/2025 at 07:02, 1 year 1 month ago

Press release: Leonteq expands market presence with leverage products on BX Swiss
Leonteq expands market presence with leverage products on BX Swiss, launching over 5,000 products with leading execution quality and strategic growth plans

Switzerland Leonteq BX Swiss Market Presence Leverage Products
PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 1 month ago

Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options
Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options

Germany Sandoz Antithrombotic Treatment Rivaroxaban Generic Medicine
PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 1 month ago

SoftwareOne reports revenue decline and improved margin as expected in H1 2025; Crayon integration on track
SoftwareOne Holding AG reports revenue decline and improved margin in H1 2025, including Crayon integration progress. Company outlook focuses on growth and synergy achievements

Revenue Decline SoftwareOne Margin Improvement H1 2025 Crayon Integration
PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 1 month ago

Positive development across all major KPI: STRABAG on track for profitable growth
STRABAG SE announces positive first half 2025 results with output up by 7% to €8.9 billion, order backlog at €28.4 billion (+13%), and EBIT increased by 58% to €129.4 million. Expansion into Australia contributing to growth

Profitable Growth STRABAG SE EBIT Growth First Half 2025 Results Output Increase
REGULATED PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 1 month ago

Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, marking a significant milestone in developing therapies for muscle loss in aging individuals

Biophytis Sarcopenia Phase 3 EMA Belgian Regulatory Approval
PRESS RELEASE

published on 08/28/2025 at 07:00, 1 year 1 month ago

Exail strengthens its position in the surface drone sector with the first sale of a new long-range DriX drone model
Exail Technologies announces the sale of the DriX H-9, expanding its autonomous surface drone solutions for civil and defense markets. The H-9 offers enhanced capabilities for maritime missions

Exail Technologies Defense Applications Autonomous Drones DriX H-9 Maritime Missions
PRESS RELEASE

published on 08/28/2025 at 06:59, 1 year 1 month ago

Biophytis Receives EMA and Belgian Regulatory Approval to Initiate Phase 3 Sarcopenia Clinical Trial
Biophytis receives EMA and Belgian regulatory approval for Phase 3 sarcopenia clinical trial, enabling patient enrolment in Belgium and collaboration with European centers

Biophytis Sarcopenia Phase 3 EMA Approval Belgian Regulatory Approval

Accesswire

Published on 10/19/2026 at 23:30, 7 hours 25 minutes ago

Quanta AI Completes Name Change
Published on 10/19/2026 at 23:20, 7 hours 35 minutes ago

CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 7 hours 55 minutes ago

Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 8 hours 5 minutes ago

Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 8 hours 54 minutes ago

Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing

View all ACCESSWIRE

EQS Group

Published on 10/20/2026 at 06:45, 10 minutes ago

HUBER+SUHNER increases sales in the first nine months of 2026
Published on 10/20/2026 at 06:45, 10 minutes ago

ABB joint venture with Mitsubishi Electric to expand position in Asia-Pacific markets
Published on 10/20/2026 at 06:30, 25 minutes ago

Comet: Net sales growth accelerates further in Q3/26
Published on 10/19/2026 at 22:16, 8 hours 39 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 9 hours 32 minutes ago

EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements

Les Echos

Published on 10/19/2026 at 18:40, 12 hours 15 minutes ago

Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:00, 12 hours 55 minutes ago

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 17:45, 13 hours 10 minutes ago

Weekly share buyback
Published on 10/19/2026 at 17:45, 13 hours 10 minutes ago

Declaration of transactions on own shares from October 12, 2026 to October 18, 2026
Published on 10/19/2026 at 17:40, 13 hours 15 minutes ago

Schneider Electric launches a c. €6.0 billion capital increase, without shareholders’ preferential subscription rights, to partially finance the acquisition of PTC Inc.

View all LES ECHOS COMFI WIRE